Źródło: FDA News · licencja/uwagi: US Government work / public domain (FDA)
Materiał na podstawie oficjalnego komunikatu FDA News. Źródło: FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery. US Government work / public domain (FDA).
Na podstawie oficjalnego komunikatu FDA News: The U.S.
The U.S. Food and Drug Administration today granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab-gxly) that may allow some patients with locally advanced rectal cancer to avoid common treatments that can have a lasting impact on their daily life. — FDA News
Szczegóły, pełny kontekst i ewentualne aktualizacje: http://www.fda.gov/news-events/press-announcements/fda-approves-immunotherapy-may-allow-certain-patients-rectal-cancer-avoid-chemotherapy-radiation-and.
Źródło: FDA News — oryginał
Licencja / zasady użycia: US Government work / public domain (FDA)
Zdjęcie: DVIDSHUB — Public domain (File:Flickr – DVIDSHUB – California Marine awarded for community service in Times Square ceremony prior to Afghan deployment (Image 1 of 3).jpg)
